News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

OncLive TV

Laura Metcalfe on Alternative Medicine

ByLaura Metcalfe, MSN, RN

March 8th 2011

Dr. Pearlstone on Practice Changing Studies

ByDavid Pearlstone, MD

March 8th 2011

Dr. Pearlstone on Technological Challenges

ByDavid Pearlstone, MD

March 8th 2011

Dr. Pearlstone on the John Theurer Cancer Center

ByDavid Pearlstone, MD

March 8th 2011

Dr. Pearlstone Describes the Young Cancer Coalition

ByDavid Pearlstone, MD

March 8th 2011

Dr. David Pearlstone, from John Theurer Cancer Center, Describes the Young Cancer Coalition

Emotional and Psychological Side Effects of Chemotherapy

ByLaura Metcalfe, MSN, RN

March 8th 2011

Dr. Perez on her Anticipated Results for ASCO and SABCS

ByEdith A. Perez, MD,

March 8th 2011

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD

Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP

FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma

Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer